The anticancer mechanism of action of selected polyphenols in triple-negative breast cancer (TNBC)

Breast cancer is a leadingcause of cancer-related deaths in women globally, with triple-negative breast cancer (TNBC) being an aggressive subtype that lacks targeted therapies and is associated with a poor prognosis. Polyphenols, naturally occurring compounds in plants, have been investigated as a p...

Full description

Bibliographic Details
Main Authors: Reyhaneh Farghadani, Rakesh Naidu
Format: Article
Language:English
Published: Elsevier 2023-09-01
Series:Biomedicine & Pharmacotherapy
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0753332223009617
_version_ 1797744095443025920
author Reyhaneh Farghadani
Rakesh Naidu
author_facet Reyhaneh Farghadani
Rakesh Naidu
author_sort Reyhaneh Farghadani
collection DOAJ
description Breast cancer is a leadingcause of cancer-related deaths in women globally, with triple-negative breast cancer (TNBC) being an aggressive subtype that lacks targeted therapies and is associated with a poor prognosis. Polyphenols, naturally occurring compounds in plants, have been investigated as a potential therapeutic strategy for TNBC. This review provides an overview of the anticancer effects of polyphenols in TNBC and their mechanisms of action. Several polyphenols, including resveratrol, quercetin, kaempferol, genistein, epigallocatechin-3-gallate, apigenin, fisetin, hesperetin and luteolin, have been shown to inhibit TNBC cell proliferation, induce cell cycle arrest, promote apoptosis, and suppress migration/invasion in preclinical models. The molecular mechanisms underlying their anticancer effects involve the modulation of several signalling pathways, such as PI3K/Akt, MAPK, STATT, and NF-κB pathways. Polyphenols also exhibit synergistic effects with chemotherapy drugs, making them promising candidates for combination therapy. The review also highlights clinical trials investigating the potential use of polyphenols, individually or in combination therapy, against breast cancer. This review deepens the under-standing of the mechanism of action of respective polyphenols and provides valuable insights into the potential use of polyphenols as a therapeutic strategy for TNBC, and lays the groundwork for future research in this area.
first_indexed 2024-03-12T15:04:49Z
format Article
id doaj.art-ded69c218eb74b62b96149a98265d9db
institution Directory Open Access Journal
issn 0753-3322
language English
last_indexed 2024-03-12T15:04:49Z
publishDate 2023-09-01
publisher Elsevier
record_format Article
series Biomedicine & Pharmacotherapy
spelling doaj.art-ded69c218eb74b62b96149a98265d9db2023-08-13T04:52:51ZengElsevierBiomedicine & Pharmacotherapy0753-33222023-09-01165115170The anticancer mechanism of action of selected polyphenols in triple-negative breast cancer (TNBC)Reyhaneh Farghadani0Rakesh Naidu1Corresponding authors.; Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Jalan Lagoon Selatan, Bandar Sunway, Selangor Darul Ehsan 47500, MalaysiaCorresponding authors.; Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Jalan Lagoon Selatan, Bandar Sunway, Selangor Darul Ehsan 47500, MalaysiaBreast cancer is a leadingcause of cancer-related deaths in women globally, with triple-negative breast cancer (TNBC) being an aggressive subtype that lacks targeted therapies and is associated with a poor prognosis. Polyphenols, naturally occurring compounds in plants, have been investigated as a potential therapeutic strategy for TNBC. This review provides an overview of the anticancer effects of polyphenols in TNBC and their mechanisms of action. Several polyphenols, including resveratrol, quercetin, kaempferol, genistein, epigallocatechin-3-gallate, apigenin, fisetin, hesperetin and luteolin, have been shown to inhibit TNBC cell proliferation, induce cell cycle arrest, promote apoptosis, and suppress migration/invasion in preclinical models. The molecular mechanisms underlying their anticancer effects involve the modulation of several signalling pathways, such as PI3K/Akt, MAPK, STATT, and NF-κB pathways. Polyphenols also exhibit synergistic effects with chemotherapy drugs, making them promising candidates for combination therapy. The review also highlights clinical trials investigating the potential use of polyphenols, individually or in combination therapy, against breast cancer. This review deepens the under-standing of the mechanism of action of respective polyphenols and provides valuable insights into the potential use of polyphenols as a therapeutic strategy for TNBC, and lays the groundwork for future research in this area.http://www.sciencedirect.com/science/article/pii/S0753332223009617Anticancer agentPhytochemicalsChemosensitivityStilbenesFlavonoidsHormone receptor-negative
spellingShingle Reyhaneh Farghadani
Rakesh Naidu
The anticancer mechanism of action of selected polyphenols in triple-negative breast cancer (TNBC)
Biomedicine & Pharmacotherapy
Anticancer agent
Phytochemicals
Chemosensitivity
Stilbenes
Flavonoids
Hormone receptor-negative
title The anticancer mechanism of action of selected polyphenols in triple-negative breast cancer (TNBC)
title_full The anticancer mechanism of action of selected polyphenols in triple-negative breast cancer (TNBC)
title_fullStr The anticancer mechanism of action of selected polyphenols in triple-negative breast cancer (TNBC)
title_full_unstemmed The anticancer mechanism of action of selected polyphenols in triple-negative breast cancer (TNBC)
title_short The anticancer mechanism of action of selected polyphenols in triple-negative breast cancer (TNBC)
title_sort anticancer mechanism of action of selected polyphenols in triple negative breast cancer tnbc
topic Anticancer agent
Phytochemicals
Chemosensitivity
Stilbenes
Flavonoids
Hormone receptor-negative
url http://www.sciencedirect.com/science/article/pii/S0753332223009617
work_keys_str_mv AT reyhanehfarghadani theanticancermechanismofactionofselectedpolyphenolsintriplenegativebreastcancertnbc
AT rakeshnaidu theanticancermechanismofactionofselectedpolyphenolsintriplenegativebreastcancertnbc
AT reyhanehfarghadani anticancermechanismofactionofselectedpolyphenolsintriplenegativebreastcancertnbc
AT rakeshnaidu anticancermechanismofactionofselectedpolyphenolsintriplenegativebreastcancertnbc